OWC Pharmaceutical Research Corp (OWCP)

[Triple9]

The more I research Jeffrey Friedland, the more I like his vision of $OWCP in 3 years.

If you haven't watched the video, please do: http://www.marketwired.com/press-release/cfn-media-exclusive-interview-with-jeffrey-friedland-advisory-board-member-owc-pharmaceutical-otcqb-owcp-2186139.htm

Mr. Friedland has over 5,000,000 shares of OWCP. Based on today's share price, he's an OWCP millionaire 3 times over.

However, the share price today, in 6 months, or even 12 months is not what's motivating Mr. Friedland. He's looking 3+ years out, specifically, at this:

Multiple Myeloma (Cancer)
• Designed to be an Orphan Disease study approved by the FDA
• In-vitro study completed 06/2015 – Cannabis kills the MM cancer cells
• Pre-clinic study on mice completed 12/2015 – calibration phase for dosage,
found most effective ratio of active cannabinoids THC/CBD
• In-vitro study for a combination of 4 approved drugs with cannabis completed
05/2016 – promising results
• Pre-clinic study for the most effective combination on mice with new cannabis
extracts. On-going testing.
• SUBJECT TO ACHIEVING SCIENTIFIC MILESTONES THE COMPANY WILL
SUBMITT AN APPLICATION WITH THE FDA FOR AN ORPHAN DISEASE
DESIGNATION

http://www.owcpharma.com/wp-content/uploads/2017/01/OWC-PPT-1-2017-FINAL.pdf

What will OWCP's PPS be in 3 years? They will be generating something like $10 Million a month in sales of psoriasis, acne, and other cremes (Mr. Friedland called OWCP's psoriasis creme a "cookie cutter" rollout that can be applied to several other skin conditions), will have advised who knows how many States, Governments, Countries on their MMJ initiatives, and they will be licensing their sublingual tablet/creme/nasal spray delivery systems to a host of other MMJ companies.

Those 3 things alone will have us at an impressive PPS. But the Multiple Myeloma trails will be in Phase 1 or 2 in three years, and that is going to play largely into the share price.

Buckle up! $OWCP is going to be an awesome ride over the next 3-5 years!